Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) had Operating Cash Flow per Share of $-0.08 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.53M |
|
-- |
|
-- |
|
$6.08M |
|
$-6.08M |
|
$0.53M |
|
$-5.55M |
|
$-5.55M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-5.53M |
|
$-6.08M |
|
$-5.22M |
|
40.85M |
|
40.85M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$72.66M |
|
$3.27M |
|
$19.48M |
|
$92.14M |
|
$12.00M |
|
-- |
|
$13.66M |
|
$25.66M |
|
$66.48M |
|
$52.81M |
|
$66.48M |
|
40.85M |
|
| Cash Flow Statement Financials | |
$-3.37M |
|
$0.06M |
|
-- |
|
$71.85M |
|
$67.19M |
|
$-4.66M |
|
$0.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.32% |
|
-10.48% |
|
-6.01% |
|
-8.32% |
|
$1.63 |
|
$-0.08 |
|
|
Operating Cash Flow per Share |
$-0.08 |